应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02159 麦迪卫康
未开盘 09-01 14:37:45
1.740
-0.010
-0.57%
最高
1.790
最低
1.740
成交量
25.60万
今开
1.750
昨收
1.750
日振幅
2.86%
总市值
5.85亿
流通市值
5.85亿
总股本
3.36亿
成交额
45.12万
换手率
0.08%
流通股本
3.36亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
麦迪卫康更新8月股份变动月报表,总股本增至336,480,000股
公告速递 · 09-01 17:15
麦迪卫康更新8月股份变动月报表,总股本增至336,480,000股
麦迪卫康(02159)根据配售协议发行配售股份5648万股
智通财经 · 08-31 18:02
麦迪卫康(02159)根据配售协议发行配售股份5648万股
麦迪卫康配售56,480,000股新股,配售价1.50港元/股
公告速递 · 08-31 18:01
麦迪卫康配售56,480,000股新股,配售价1.50港元/股
麦迪卫康(02159.HK)完成配售5648万股 净筹约7999万港元
智通财经 · 08-31 17:36
麦迪卫康(02159.HK)完成配售5648万股 净筹约7999万港元
麦迪卫康(02159)完成特別授权配售 募资约84.72百万港元
公告速递 · 08-31 17:33
麦迪卫康(02159)完成特別授权配售 募资约84.72百万港元
麦迪卫康2026年中期财报营收2.31亿元,净利润17.8百万元
公告速递 · 08-03
麦迪卫康2026年中期财报营收2.31亿元,净利润17.8百万元
麦迪卫康更新2026年7月股份变动月报表,股本维持稳定
公告速递 · 08-03
麦迪卫康更新2026年7月股份变动月报表,股本维持稳定
港股异动丨麦迪卫康盘中大涨逾10% 中期收入2.3亿大增82% AI已成绝对主导引擎
格隆汇 · 08-03
港股异动丨麦迪卫康盘中大涨逾10% 中期收入2.3亿大增82% AI已成绝对主导引擎
港股异动 | 麦迪卫康(02159.HK)绩后涨超9% 上半年拥有人应占溢利1790.3万元 持续巩固专病模型建设
智通财经 · 08-03
港股异动 | 麦迪卫康(02159.HK)绩后涨超9% 上半年拥有人应占溢利1790.3万元 持续巩固专病模型建设
麦迪卫康(02159.HK)公布中期业绩 拥有人应占溢利1790.3万元 同比扭亏为盈
智通财经 · 07-31
麦迪卫康(02159.HK)公布中期业绩 拥有人应占溢利1790.3万元 同比扭亏为盈
麦迪卫康(02159.HK)2026年中期营收2.31亿元 AI平台占比逾八成实现扭亏为盈
公告速递 · 07-31
麦迪卫康(02159.HK)2026年中期营收2.31亿元 AI平台占比逾八成实现扭亏为盈
麦迪卫康(02159)发布正面盈利预告 上半年预盈不低于人民币1,700万元
公告速递 · 07-28
麦迪卫康(02159)发布正面盈利预告 上半年预盈不低于人民币1,700万元
麦迪卫康中期营收预增超80%,AI相关收入占比超八成
美股速递 · 07-28
麦迪卫康中期营收预增超80%,AI相关收入占比超八成
麦迪卫康:预计2026年上半年净利润至少达1700万元
美股速递 · 07-28
麦迪卫康:预计2026年上半年净利润至少达1700万元
麦迪卫康(02159)发盈喜 预计中期纯利不少于1700万元 同比扭亏为盈
智通财经 · 07-28
麦迪卫康(02159)发盈喜 预计中期纯利不少于1700万元 同比扭亏为盈
麦迪卫康(02159)定于7月31日召开董事会 审议2026年中期业绩及股息事宜
公告速递 · 07-21
麦迪卫康(02159)定于7月31日召开董事会 审议2026年中期业绩及股息事宜
麦迪卫康更新6月股份变动月报表,股本维持稳定
公告速递 · 07-02
麦迪卫康更新6月股份变动月报表,股本维持稳定
麦迪卫康授予董事股份购回授权,规模达已发行股本一成
公告速递 · 06-05
麦迪卫康授予董事股份购回授权,规模达已发行股本一成
麦迪卫康更新2026年5月股份变动月报表,股本维持稳定
公告速递 · 06-01
麦迪卫康更新2026年5月股份变动月报表,股本维持稳定
寻找下一个AI医疗价值“洼地”,深度对话麦迪卫康CEO
格隆汇 · 05-29
寻找下一个AI医疗价值“洼地”,深度对话麦迪卫康CEO
加载更多
公司概况
公司名称:
麦迪卫康
所属市场:
SEHK
上市日期:
--
主营业务:
麦迪卫康健康医疗管理科技股份有限公司是一家主要提供综合医疗营销解决方案的投资控股公司。该公司主要提供的服务包括医学会议服务、数字营销解决方案服务、患者教育及自测服务、营销战略和咨询服务、合约研究机构(CRO)服务以及互联网医院服务。该公司已推出医会+应用程序(App),方便用户提交现场会议请求及监察会议进行。该公司主要在中国市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02159","market":"HK","secType":"STK","nameCN":"麦迪卫康","latestPrice":1.74,"timestamp":1788244665211,"preClose":1.75,"halted":0,"volume":256000,"delay":0,"changeRate":-0.0057142857142857195,"floatShares":336000000,"shares":336000000,"eps":0.0438,"marketStatus":"未开盘","change":-0.01,"latestTime":"09-01 14:37:45","open":1.75,"high":1.79,"low":1.74,"amount":451208,"amplitude":0.028571,"askPrice":1.8,"askSize":8000,"bidPrice":1.72,"bidSize":32000,"shortable":0,"etf":0,"ttmEps":0.14,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788312600000},"marketStatusCode":0,"adr":0,"listingDate":1610985600000,"exchange":"SEHK","adjPreClose":1.75,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"volumeRatio":1.5841584148612882,"lotSize":8000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02159","defaultTab":"news","newsList":[{"id":"1103166694","title":"麦迪卫康更新8月股份变动月报表,总股本增至336,480,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1103166694","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103166694?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:15","pubTimestamp":1788254148,"startTime":"0","endTime":"0","summary":"麦迪卫康健康医疗管理科技股份有限公司于2026年9月1日披露了截至2026年8月31日止的股份变动月报表。报告显示,公司在8月期间法定注册股本维持380,000港元,与上个月持平。截至8月底,公司已满足香港联交所的最低公众持股量要求。截至本月底,公司股本总数由280,000,000股增至336,480,000股。公司方面表示,将持续遵守香港联交所《上市规则》及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071400","title":"麦迪卫康(02159)根据配售协议发行配售股份5648万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663071400?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:02","pubTimestamp":1788170543,"startTime":"0","endTime":"0","summary":"智通财经APP讯,麦迪卫康(02159)发布公告,根据日期为2026年3月30日的配售协议(经不时修订及补充),于2026年8月31日配发及发行配售股份5648万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02159","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124846050","title":"麦迪卫康配售56,480,000股新股,配售价1.50港元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=1124846050","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124846050?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:01","pubTimestamp":1788170491,"startTime":"0","endTime":"0","summary":"麦迪卫康(02159)于2026年8月31日公告,根据2026年3月30日签署并经多次修订与补充的配售协议,公司在当日配发及发行合共56,480,000股新股,约占发行前已发行股本的20.17%。每股发行价格为1.50港元,涉及金额约8,472.00万港元。完成后,公司已发行股本由280,000,000股增至336,480,000股,库藏股数为0股。\n公司确认,本次股份发行已获得董事会正式授权,并已遵守香港联合交易所有限公司证券上市规则、相关法律及其他监管规定。上述公告由公司秘书陈明媚签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"麦迪卫康配售56,480,000股新股,配售价1.50港元/股","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079652","title":"麦迪卫康(02159.HK)完成配售5648万股 净筹约7999万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079652","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663079652?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:36","pubTimestamp":1788168963,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02159","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181487662","title":"麦迪卫康(02159)完成特別授权配售 募资约84.72百万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181487662","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181487662?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:33","pubTimestamp":1788168786,"startTime":"0","endTime":"0","summary":"2026年8月31日,麦迪卫康健康医疗管理科技股份有限公司公告称,按照先前订立并经修订及补充的配售协议,特別授权配售已于2026年8月31日完成。公司向不少于六名承配人配售合共56,480,000股新股,每股配售价1.50港元。本次配售股份数量占配售完成前已发行股本总额约20.17%,占经配售扩大的已发行股本总额约16.79%。公司董事会表示,配售顺利完成有助于为收购事项提供现金对价资金,优化资本结构并增强财务灵活性。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145985503","title":"麦迪卫康2026年中期财报营收2.31亿元,净利润17.8百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145985503","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145985503?lang=zh_cn&edition=full","pubTime":"2026-08-03 19:12","pubTimestamp":1785755574,"startTime":"0","endTime":"0","summary":"截至2026年6月30日,麦迪卫康实现营收2.31亿元人民币,同比增加81.7%。毛利率为30.2%,较去年同期提升13.1个百分点。报告期销售和管理等综合成本结构有所优化,销售成本达161.2百万元,同比增长53.1%;销售开支为8.2百万元,同比增长9.3%;行政开支17.2百万元,同比下降8%。研发投入规模扩大至29.8百万元,占收入比重进一步提升,相比去年同期增长373%。运营活动所用现金净额为20.3百万元,同比上升约4%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"麦迪卫康2026年中期财报营收2.31亿元,净利润17.8百万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198169413","title":"麦迪卫康更新2026年7月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1198169413","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198169413?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:31","pubTimestamp":1785749474,"startTime":"0","endTime":"0","summary":"麦迪卫康健康医疗管理科技股份有限公司于2026年8月3日发布2026年7月股份变动月报表,报告期截至2026年7月31日。根据公告,公司法定股本共计38,000,000,000股,面值为每股0.00001港元,注册股本总额为380,000港元。该数据与上月保持一致。截至2026年7月末,公司确认符合香港联合交易所有限公司相关上市规则要求,维持了足够的公众持股量。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656342321","title":"港股异动丨麦迪卫康盘中大涨逾10% 中期收入2.3亿大增82% AI已成绝对主导引擎","url":"https://stock-news.laohu8.com/highlight/detail?id=2656342321","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656342321?lang=zh_cn&edition=full","pubTime":"2026-08-03 11:01","pubTimestamp":1785726099,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1219","02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656342810","title":"港股异动 | 麦迪卫康(02159.HK)绩后涨超9% 上半年拥有人应占溢利1790.3万元 持续巩固专病模型建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2656342810","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656342810?lang=zh_cn&edition=full","pubTime":"2026-08-03 10:53","pubTimestamp":1785725582,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02159","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655744363","title":"麦迪卫康(02159.HK)公布中期业绩 拥有人应占溢利1790.3万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2655744363","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655744363?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:36","pubTimestamp":1785497783,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1219","02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142900461","title":"麦迪卫康(02159.HK)2026年中期营收2.31亿元 AI平台占比逾八成实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1142900461","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142900461?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:35","pubTimestamp":1785497750,"startTime":"0","endTime":"0","summary":"2026年7月31日,麦迪卫康健康医疗管理科技股份有限公司披露截至2026年6月30日止六个月未经审核中期业绩。公司期内实现收入2.31亿元,同比增长81.7%。其中,AI数字智能平台贡献收入1.94亿元,占总收入84.1%。毛利为69.7百万元,同比增长219.7%,毛利率由上年同期的17.1%提升至30.2%,增加13.1个百分点。期内录得溢利17.8百万元,而上年同期为亏损4.1百万元,公司由亏转盈。董事会决定不派发2026年中期股息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101289072","title":"麦迪卫康(02159)发布正面盈利预告 上半年预盈不低于人民币1,700万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1101289072","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101289072?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:21","pubTimestamp":1785230497,"startTime":"0","endTime":"0","summary":"麦迪卫康健康医疗管理科技股份有限公司(02159)7月28日发布正面盈利预告,预计截至2026年6月30日止六个月实现纯利不少于人民币1,700万元,而上年同期录得亏损约人民币410万元。公司由亏转盈主要受以下因素推动:\n1. 报告期内集团收入同比增长逾80%,其中AI相关收入占比已超过80%; \n2. 集团毛利率提升至30%以上。\n公司指出,相关数据基于未经审计的综合管理账目及董事会对现有资料的初步评估,最终中期业绩将于2026年7月31日公布。公司提醒股东及潜在投资者在买卖公司证券时应审慎行事。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186173781","title":"麦迪卫康中期营收预增超80%,AI相关收入占比超八成","url":"https://stock-news.laohu8.com/highlight/detail?id=1186173781","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186173781?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:18","pubTimestamp":1785230289,"startTime":"0","endTime":"0","summary":"麦迪卫康医疗管理科技有限公司(MediWelcome Healthcare Management & Technology)预期中期营收同比增长逾80%,其中AI相关业务贡献了总收入的八成以上。这一迅猛增长态势,彰显出公司在人工智能领域的深耕取得了显著成效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02159","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136787527","title":"麦迪卫康:预计2026年上半年净利润至少达1700万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136787527","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136787527?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:18","pubTimestamp":1785230289,"startTime":"0","endTime":"0","summary":"麦迪卫康健康管理科技有限公司(Mediwelcome Healthcare Management & Technology)今日发布业绩预告,预计截至2026年6月30日的六个月内,公司净利润将不低于人民币1700万元。这一盈利预期,彰显了公司在该财年上半年的稳健经营态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654564070","title":"麦迪卫康(02159)发盈喜 预计中期纯利不少于1700万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2654564070","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654564070?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:18","pubTimestamp":1785230288,"startTime":"0","endTime":"0","summary":"智通财经APP讯,麦迪卫康(02159)发布公告,董事会预期集团于截至2026年6月30日止六个月的中期业绩将录得显著增长,并录得纯利不少于人民币1700万元,而截至2025年6月30日止六个月则录得约人民币410万元亏损。本期间由亏转盈,主要由以下因素所致:(1)集团收入较上年同期增长逾80%,其中AI相关收入占比已超过80%;及(2)集团毛利率上升至30%以上。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1473111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"麦迪卫康(02159)发盈喜 预计中期纯利不少于1700万元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143002230","title":"麦迪卫康(02159)定于7月31日召开董事会 审议2026年中期业绩及股息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1143002230","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143002230?lang=zh_cn&edition=full","pubTime":"2026-07-21 16:56","pubTimestamp":1784624165,"startTime":"0","endTime":"0","summary":"麦迪卫康健康医疗管理科技股份有限公司(02159)7月21日在港交所公告称,董事会已排期于2026年7月31日(星期五)召开会议,拟审议及批准公司及其附属公司截至2026年6月30日止六个月的中期业绩报告及其发布事宜,同时考虑派发中期股息(如有),并处理其他事项。\n公告显示,董事会目前由四名执行董事施炜、杨为民、王亮及邓承英,一名非执行董事刘夏,以及三名独立非执行董事宋瑞霖、王正及陈会林组成。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138245827","title":"麦迪卫康更新6月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1138245827","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138245827?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:51","pubTimestamp":1782982314,"startTime":"0","endTime":"0","summary":"麦迪卫康健康医疗管理科技股份有限公司于2026年7月2日发布截至2026年6月30日的股份变动月报表。公告显示,经本期统计,公司已发行股本及注册股本保持不变。据了解,公司法定注册股本为38,000,000,000股,面值为每股0.00001港元,注册股本总额为380,000港元。本月报由公司秘书陈明媚签署。根据公告,截至2026年6月30日,公司股本维持稳定,未出现新增发行或回购股份等活动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164880646","title":"麦迪卫康授予董事股份购回授权,规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1164880646","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164880646?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:03","pubTimestamp":1780650216,"startTime":"0","endTime":"0","summary":"麦迪卫康拟于股东周年大会上向董事会授出股份购回授权。董事会称,此次授权主要依据开曼群岛及上市规则相关法律规定,资金将合法从公司可动用的财务资源中拨付,旨在提升股东回报并优化公司资本结构。董事会认为,如获股东正式批准,购回计划符合公司及股东的最佳利益,并将在股东周年大会后根据市况及公司财务安排择机实施。董事会强调,此次购回授权最终以股东大会通过为准,并受到香港联交所规则以及公司组织章程细则的约束。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"麦迪卫康授予董事股份购回授权,规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110470135","title":"麦迪卫康更新2026年5月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1110470135","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110470135?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:36","pubTimestamp":1780306617,"startTime":"0","endTime":"0","summary":"麦迪卫康健康医疗管理科技股份有限公司于2026年6月1日披露了截至2026年5月31日的股份变动月报表。根据公告,公司的法定/注册股本为38,000,000,000股普通股,每股面值为0.00001港元,总额为380,000港元;本月并无调整,月末与上月持平。公告显示,普通股方面,截至5月末已发行股份总数为280,000,000股,库藏股为0股,均与上月持平。期间未进行新增发行、购回、注销及库藏股变动。截至本月末,麦迪卫康已满足相关规定的公众持股量要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639864982","title":"寻找下一个AI医疗价值“洼地”,深度对话麦迪卫康CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2639864982","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639864982?lang=zh_cn&edition=full","pubTime":"2026-05-29 12:58","pubTimestamp":1780030720,"startTime":"0","endTime":"0","summary":"站在全球数字医疗的坐标系中,麦迪卫康的资产与估值水平之间,横亘着一条显而易见的鸿沟。","market":"fut","thumbnail":"https://img2.gelonghui.com/9b3dd-8036aaa2-619b-45ad-871c-ace1794926c5.jpg?guru_height=682&guru_width=1280&guru_size=168785","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/9b3dd-8036aaa2-619b-45ad-871c-ace1794926c5.jpg?guru_height=682&guru_width=1280&guru_size=168785"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4980016","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1219","ARTY","AIPO","CHAT","159891","02159","AGIX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mediwelcome.com","stockEarnings":[{"period":"1week","weight":-0.0225},{"period":"1month","weight":0.061},{"period":"3month","weight":0.0419},{"period":"6month","weight":0.1523},{"period":"1year","weight":0.0943},{"period":"ytd","weight":0.4872}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":-0.0214},{"period":"3month","weight":-0.0118},{"period":"6month","weight":0.0003},{"period":"1year","weight":-0.0112},{"period":"ytd","weight":-0.0117}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"麦迪卫康健康医疗管理科技股份有限公司是一家主要提供综合医疗营销解决方案的投资控股公司。该公司主要提供的服务包括医学会议服务、数字营销解决方案服务、患者教育及自测服务、营销战略和咨询服务、合约研究机构(CRO)服务以及互联网医院服务。该公司已推出医会+应用程序(App),方便用户提交现场会议请求及监察会议进行。该公司主要在中国市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.020559},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.040303},{"month":3,"riseRate":0.333333,"avgChangeRate":0.033262},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.064287},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.077496},{"month":6,"riseRate":0.833333,"avgChangeRate":0.20324},{"month":7,"riseRate":0.5,"avgChangeRate":0.080893},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.112905},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.077703},{"month":10,"riseRate":0.2,"avgChangeRate":-0.003045},{"month":11,"riseRate":0.6,"avgChangeRate":0.036715},{"month":12,"riseRate":0.4,"avgChangeRate":0.142956}],"exchange":"SEHK","name":"麦迪卫康","nameEN":"MEDIWELCOME"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"麦迪卫康(02159)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供麦迪卫康(02159)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"麦迪卫康,02159,麦迪卫康股票,麦迪卫康股票老虎,麦迪卫康股票老虎国际,麦迪卫康行情,麦迪卫康股票行情,麦迪卫康股价,麦迪卫康股市,麦迪卫康股票价格,麦迪卫康股票交易,麦迪卫康股票购买,麦迪卫康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"麦迪卫康(02159)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供麦迪卫康(02159)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}